Compare BOF & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOF | BTMD |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 65.8M |
| IPO Year | 2023 | 2021 |
| Metric | BOF | BTMD |
|---|---|---|
| Price | $4.29 | $1.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 19.3K | ★ 212.2K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.33 | ★ 722.22 |
| EPS | N/A | ★ N/A |
| Revenue | $3,184,018.00 | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.20 | N/A |
| 52 Week Low | $1.93 | $1.27 |
| 52 Week High | $5.25 | $3.61 |
| Indicator | BOF | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 31.74 |
| Support Level | $2.86 | $1.35 |
| Resistance Level | $4.29 | $1.69 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 46.77 | 8.33 |
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients. The products are mainly sold through three channels: branded retail snack products, private label products for retailers, and fruit and vegetable ingredients sold to food manufacturers.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.